San Francisco Bay Area biotech stories.
Tuesday, July 10, 2012
Nektar Therapeutics raises $125 million in debt deal
raised $125 million by selling debt due in 2017. It will spend the money paying off other debt due this year.
San Francisco-based Nektar (NASDAQ: NKTR) sold $125 million in senior secured notes in a private placement. The sale should close July 11. Nektar will spend the money paying off convertible subordinated notes due Sept. 28, 2012.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)